ESC 2021: Late-breaking Science Video Collection

Published: 02 September 2021

  • Views:

    Views Icon 6256

  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating

Overview

Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provide a concise analysis of the late-breaking science results and spotlight impactful data. 

For a deeper dive into key clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series. 

Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.

More from this programme

Part 1

View from the Thoraxcenter

In the latest episode View from the Thoraxcenter, Professor Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their concise analysis of the hot line and late-breaking trials that will be presented at ESC Congress 2021. What presentations should we look at for this weekend? Get your update on the importance of trials such as GUIDE-HF, MASTER DAPT, TOMAHAWK and many more delivered by our world-class experts, Professor Van Mieghem and Dr Joost Daemen.
2 sessions
View from the Thoraxcenter – What's Hot at ESC 2021 Watch now
View from the Thoraxcenter: ESC 21 Late-breaking Science Wrap Up Watch now

Part 2

Late-breaker Discussion Series

Host, Dr Harriette Van Spall interviews the late-breaker and hot line presenters of ESC Congress 2021.
3 sessions
ESC 2021 Discussion: The EMPEROR-Preserved Trial Watch now
ESC 2021 Discussion: The FIGARO-DKD Trial Watch now
ESC 2021 Discussion: The EMPEROR-Pooled Study Watch now

Part 3

Expert Interviews

Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
11 sessions
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI Watch now
SYNTAX II Trial: 5yr Data Shows Reduction in MACE in PCI Watch now
TWILIGHT-HBR: Ticagrelor Monotherapy in HBR Patients Undergoing PCI Watch now
The LAAOS III Study: Surgical AFIB Ablation Evaluation Watch now
TWILIGHT-Stent: Ticagrelor Monotherapy According to Stent Type Watch now
STOPDAPT-2 ACT: 1-Month DAPT Followed by Clopidogrel Monotherapy in ACS Watch now
SPLENDOR: Metabolic Surgery and Risk of MACE in NASH Watch now
RESPONSE-2: Benefits of Community-based Lifestyle Programme Were Lost After 1yr in CAD Patients Watch now
VOYAGER PAD: Rivaroxaban in Symptomatic PAD With & Without Comorbid Diabetes Watch now
Micra CED: 2-Year Outcomes with Leadless Pacing Watch now
RIPCORD 2: FFR During Angiography Did Not Improve Patient Outcomes Watch now

Part 4

Masterclass with Dr Harriette Van Spall & Dr Birgit Vogel

In the ESC Congress 2021 episode of the Masterclass video series, host, Dr Harriette Van Spall (McMaster University, CA) meets with Dr Birgit Vogel (Icahn School of Medicine at Mount Sinai, US), one of the commissioners and first author of the "The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030" report.
1 session
Masterclass on The Global Burden of CV Disease in Women Watch now

Faculty Biographies

Richard Whitlock

Richard Whitlock

Richard Whitlock is a Professor of Surgery at McMaster University and a practising cardiac surgeon at Hamilton Health Sciences, Canada. Previously, he held a full-time research appointment at the Population Health Research Institute. He completed his residency in cardiac surgery in 2007, a fellowship in critical care in 2008, and a research fellowship in 2012. He holds both an MSc and PhD in Health Research Methodology – Clinical Epidemiology from McMaster University. Dr Whitlock has published over 120 papers in journals including The Lancet, Circulation, Anesthesiology, Journal of the American College of Cardiology, European Heart Journal, New England Journal of Medicine, and Thrombosis and Haemostasis.

View full profile